TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 79 filers reported holding TRINITY BIOTECH PLC in Q2 2016. The put-call ratio across all filers is 3.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $95,000 | -79.1% | 15,900 | -53.7% | 0.01% | -81.2% |
| Q3 2016 | $454,000 | +131.6% | 34,373 | +99.0% | 0.05% | +77.8% |
| Q2 2016 | $196,000 | -5.3% | 17,273 | -2.8% | 0.03% | -6.9% |
| Q1 2016 | $207,000 | -1.0% | 17,773 | 0.0% | 0.03% | -9.4% |
| Q4 2015 | $209,000 | +43.2% | 17,773 | +39.1% | 0.03% | +52.4% |
| Q3 2015 | $146,000 | -71.8% | 12,773 | -55.5% | 0.02% | -71.2% |
| Q2 2015 | $518,000 | -6.2% | 28,684 | 0.0% | 0.07% | -5.2% |
| Q1 2015 | $552,000 | -14.6% | 28,684 | -22.2% | 0.08% | -18.9% |
| Q4 2014 | $646,000 | -79.2% | 36,884 | -78.3% | 0.10% | -78.3% |
| Q3 2014 | $3,099,000 | +58.1% | 169,624 | +99.3% | 0.44% | +68.7% |
| Q2 2014 | $1,960,000 | +25.4% | 85,091 | +31.9% | 0.26% | +23.9% |
| Q1 2014 | $1,563,000 | +35.2% | 64,500 | +40.2% | 0.21% | +10.0% |
| Q4 2013 | $1,156,000 | +67.5% | 46,000 | +12.4% | 0.19% | +28.4% |
| Q2 2013 | $690,000 | +44.4% | 40,929 | +44.6% | 0.15% | +66.3% |
| Q1 2013 | $478,000 | – | 28,314 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |